Tenecteplase No Longer Off-Label as Stroke Lytic

Watchdoq March 3, 2025
(MedPage Today) -- The FDA approved tenecteplase (TNKase) for adult stroke patients, Genentech announced on Monday.
A clot-dissolving tissue plasminogen activator (tPA), tenecteplase is now indicated for acute ischemic stroke on top of its older...

Read Full Article